Najla El Jurdi, M.D.

Trials

Studies that name Najla El Jurdi, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:44 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT06303193 · Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

  National Cancer Institute (NCI) · recruiting · Myelodysplastic Syndromes · principal investigator
• Ph1/Ph2
  NCT05918055 · Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes

  National Cancer Institute (NCI) · terminated · Myelodysplastic Syndromes · principal investigator
• Ph1/Ph2
  NCT05531786 · Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

  National Cancer Institute (NCI) · recruiting · Graft vs Host Disease · principal investigator
• Ph1/Ph2
  NCT05148234 · BMS-986253 in Myelodysplastic Syndromes

  National Cancer Institute (NCI) · terminated · Myelodysplastic Syndromes · principal investigator
• N/A
  NCT03000244 · Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

  National Cancer Institute (NCI) · recruiting · Cellular Immunotherapy, Adoptive, Genetic Therapy, Tissue Donors · principal investigator
• Ph1/Ph2
  NCT02669251 · Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

  National Cancer Institute (NCI) · active not recruiting · Chronic Graft vs Host Disease, Chronic Graft-Versus-Host Disease, Bronchiolitis Obliterans Syndrome · principal investigator
• Ph2
  NCT01688466 · Pomalidomide for Chronic Graft-versus-Host Disease

  National Cancer Institute (NCI) · completed · Graft vs Host Disease, Graft-Versus-Host Disease · principal investigator
• Ph2
  NCT01557517 · Clobetasol for Oral Graft-Versus-Host Disease

  National Cancer Institute (NCI) · completed · Oral Chronic Graft vs Host Disease · principal investigator
• N/A
  NCT00092235 · Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease

  National Cancer Institute (NCI) · recruiting · Chronic Graft vs. Host Disease · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.